4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0000921895-21-001335
Chief Executive Officer bought 11,365,921 shares at $5.24 ($59,557,426)
From the SEC's structured data for this filing
Trades in this filing
DUGGAN ROBERT W · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-12 | Purchase : show line 1 in the form | +11,365,921 | $5.24 | $59,557,426 | 67,662,454 | D |
| Open-market purchases · 11,365,921 sh · avg $5.24 · $59,557,426 | ||||||
Loading xslF345X03/form412566dug_05142021.xml…